This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kleanthous, H.
Right arrow Articles by Monath, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kleanthous, H.
Right arrow Articles by Monath, T. P.

 Previous Article  |  Next Article 

Infect Immun, June 1998, p. 2879-2886, Vol. 66, No. 6
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Rectal and Intranasal Immunizations with Recombinant Urease Induce Distinct Local and Serum Immune Responses in Mice and Protect against Helicobacter pylori Infection

Harry Kleanthous,* Gwendolyn A. Myers, Kathleen M. Georgakopoulos, Timothy J. Tibbitts, Jennifer W. Ingrassia, Heather L. Gray, Ru Ding, Zhen-Zi Zhang, Wende Lei, Richard Nichols, Cynthia K. Lee, Thomas H. Ermak, and Thomas P. Monath

OraVax, Inc., Cambridge, Massachusetts 02139

Received 29 October 1997/Returned for modification 16 December 1997/Accepted 12 March 1998

To determine the optimal inductive sites for immunization against Helicobacter pylori infection, the protective efficacy of recombinant urease (rUre) was assessed for mice given the vaccine by either the oral (p.o.), intranasal (i.n.), or rectal route. When mice were immunized with rUre (25 µg p.o. or rectally or 10 µg i.n.) plus heat-labile toxin from Escherichia coli as the mucosal adjuvant, all routes afforded protection against challenge with H. pylori, as indicated by a significant reduction in gastric urease activity (P < 0.0005) compared to that of sham-immunized controls. Quantitative H. pylori culture of stomach tissue demonstrated a >97% reduction in bacterial burden in mice immunized by all routes (P < 0.05). Induction of antiurease immunoglobulin A (IgA) levels in gastric luminal secretions after p.o. immunization was greater than after i.n. administration (means, 6.0 and 1.02 ng/ml, respectively) and was dependent upon challenge with H. pylori. However, immunization by the rectal route resulted in the generation of the highest levels of gastric antiurease IgA (mean, 40.89 ng/ml), which was detectable prior to challenge with H. pylori. Immunohistochemical staining of stomach tissue for cells secreting urease-specific antibody and CD4+ T cells showed levels of recruitment to be dependent upon challenge with H. pylori and equivalent for all routes. These results identify both the rectum and nasal passages as suitable inductive sites for urease immunization.

* Corresponding author. Mailing address: OraVax, Inc., 38 Sidney St., Cambridge, MA 02139. Phone: (617) 494-1339. Fax: (617) 494-1741. E-mail: hkleanth{at}oravax.com.

Infect Immun, June 1998, p. 2879-2886, Vol. 66, No. 6
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Gao, L., Weck, M. N., Michel, A., Pawlita, M., Brenner, H. (2009). Association between Chronic Atrophic Gastritis and Serum Antibodies to 15 Helicobacter pylori Proteins Measured by Multiplex Serology. Cancer Res. 69: 2973-2980 [Abstract] [Full Text]  
  • Taylor, J. M., Ziman, M. E., Fong, J., Solnick, J. V., Vajdy, M. (2007). Possible Correlates of Long-Term Protection against Helicobacter pylori following Systemic or Combinations of Mucosal and Systemic Immunizations. Infect. Immun. 75: 3462-3469 [Abstract] [Full Text]  
  • Agnello, D., Herve, C. A., Lavaux, A., Darniot, M., Guillon, P., Charpilienne, A., Pothier, P. (2006). Intrarectal Immunization with Rotavirus 2/6 Virus-Like Particles Induces an Antirotavirus Immune Response Localized in the Intestinal Mucosa and Protects against Rotavirus Infection in Mice.. J. Virol. 80: 3823-3832 [Abstract] [Full Text]  
  • Parez, N., Fourgeux, C., Mohamed, A., Dubuquoy, C., Pillot, M., Dehee, A., Charpilienne, A., Poncet, D., Schwartz-Cornil, I., Garbarg-Chenon, A. (2006). Rectal Immunization with Rotavirus Virus-Like Particles Induces Systemic and Mucosal Humoral Immune Responses and Protects Mice against Rotavirus Infection. J. Virol. 80: 1752-1761 [Abstract] [Full Text]  
  • Arora, S., Czinn, S. J. (2005). Vaccination as a Method of Preventing Helicobacter pylori-Associated Gastric Cancer. Cancer Epidemiol. Biomarkers Prev. 14: 1890-1891 [Full Text]  
  • Graham, D Y, Opekun, A R, Osato, M S, El-Zimaity, H M T, Lee, C K, Yamaoka, Y, Qureshi, W A, Cadoz, M, Monath, T P (2004). Challenge model for Helicobacter pylori infection in human volunteers. Gut 53: 1235-1243 [Abstract] [Full Text]  
  • Akhiani, A. A., Schon, K., Franzen, L. E., Pappo, J., Lycke, N. (2004). Helicobacter pylori-Specific Antibodies Impair the Development of Gastritis, Facilitate Bacterial Colonization, and Counteract Resistance against Infection. J. Immunol. 172: 5024-5033 [Abstract] [Full Text]  
  • Bury-Mone, S., Skouloubris, S., Dauga, C., Thiberge, J.-M., Dailidiene, D., Berg, D. E., Labigne, A., De Reuse, H. (2003). Presence of Active Aliphatic Amidases in Helicobacter Species Able To Colonize the Stomach. Infect. Immun. 71: 5613-5622 [Abstract] [Full Text]  
  • Garhart, C. A., Nedrud, J. G., Heinzel, F. P., Sigmund, N. E., Czinn, S. J. (2003). Vaccine-Induced Protection against Helicobacter pylori in Mice Lacking Both Antibodies and Interleukin-4. Infect. Immun. 71: 3628-3633 [Abstract] [Full Text]  
  • Garhart, C. A., Heinzel, F. P., Czinn, S. J., Nedrud, J. G. (2003). Vaccine-Induced Reduction of Helicobacter pylori Colonization in Mice Is Interleukin-12 Dependent but Gamma Interferon and Inducible Nitric Oxide Synthase Independent. Infect. Immun. 71: 910-921 [Abstract] [Full Text]  
  • Jiang, W., Baker, H. J., Smith, B. F. (2003). Mucosal Immunization with Helicobacter, CpG DNA, and Cholera Toxin Is Protective. Infect. Immun. 71: 40-46 [Abstract] [Full Text]  
  • Banerjee, S, Medina-Fatimi, A, Nichols, R, Tendler, D, Michetti, M, Simon, J, Kelly, C P, Monath, T P, Michetti, P (2002). Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers. Gut 51: 634-640 [Abstract] [Full Text]  
  • Londono-Arcila, P., Freeman, D., Kleanthous, H., O'Dowd, A. M., Lewis, S., Turner, A. K., Rees, E. L., Tibbitts, T. J., Greenwood, J., Monath, T. P., Darsley, M. J. (2002). Attenuated Salmonella enterica Serovar Typhi Expressing Urease Effectively Immunizes Mice against Helicobacter pylori Challenge as Part of a Heterologous Mucosal Priming-Parenteral Boosting Vaccination Regimen. Infect. Immun. 70: 5096-5106 [Abstract] [Full Text]  
  • Garhart, C. A., Redline, R. W., Nedrud, J. G., Czinn, S. J. (2002). Clearance of Helicobacter pylori Infection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized Mice. Infect. Immun. 70: 3529-3538 [Abstract] [Full Text]  
  • Smith, D.J. (2002). DENTAL CARIES VACCINES: PROSPECTS AND CONCERNS. CROBM 13: 335-349 [Abstract] [Full Text]  
  • Quiding-Jarbrink, M, Lonroth, H, Ahlstedt, I, Holmgren, J, Svennerholm, A-M (2001). Human gastric B cell responses can be induced by intestinal immunisation. Gut 49: 512-518 [Abstract] [Full Text]  
  • Jeong, J.-Y., Mukhopadhyay, A. K., Akada, J. K., Dailidiene, D., Hoffman, P. S., Berg, D. E. (2001). Roles of FrxA and RdxA Nitroreductases of Helicobacter pylori in Susceptibility and Resistance to Metronidazole. J. Bacteriol. 183: 5155-5162 [Abstract] [Full Text]  
  • Rokbi, B., Seguin, D., Guy, B., Mazarin, V., Vidor, E., Mion, F., Cadoz, M., Quentin-Millet, M.-J. (2001). Assessment of Helicobacter pylori Gene Expression within Mouse and Human Gastric Mucosae by Real-Time Reverse Transcriptase PCR. Infect. Immun. 69: 4759-4766 [Abstract] [Full Text]  
  • Radcliff, F. J., Ferrero, R. L. (2001). Effect of Low-Dose Antigen Exposure on Development of Immunity to Helicobacter pylori Infection in Mice. Infect. Immun. 69: 5186-5188 [Abstract] [Full Text]  
  • Kotloff, K. L., Sztein, M. B., Wasserman, S. S., Losonsky, G. A., DiLorenzo, S. C., Walker, R. I. (2001). Safety and Immunogenicity of Oral Inactivated Whole-Cell Helicobacter pylori Vaccine with Adjuvant among Volunteers with or without Subclinical Infection. Infect. Immun. 69: 3581-3590 [Abstract] [Full Text]  
  • Solnick, J. V., Schauer, D. B. (2001). Emergence of Diverse Helicobacter Species in the Pathogenesis of Gastric and Enterohepatic Diseases. Clin. Microbiol. Rev. 14: 59-97 [Abstract] [Full Text]  
  • Jeong, J.-Y., Berg, D. E. (2000). Mouse-Colonizing Helicobacter pylori SS1 Is Unusually Susceptible to Metronidazole Due to Two Complementary Reductase Activities. Antimicrob. Agents Chemother. 44: 3127-3132 [Abstract] [Full Text]  
  • RUIZ-BUSTOS, E., SIERRA-BELTRAN, A., ROMERO, M.J., RODRIGUEZ-JARAMILLO, C., ASCENCIO, F. (2000). Protection of BALB/c mice against experimental Helicobacter pylori infection by oral immunisation with H. pylori heparan sulphate-binding proteins coupled to cholera toxin {beta}-subunit. J Med Microbiol 49: 535-541 [Abstract] [Full Text]  
  • Solnick, J. V., Canfield, D. R., Hansen, L. M., Torabian, S. Z. (2000). Immunization with Recombinant Helicobacter pylori Urease in Specific-Pathogen-Free Rhesus Monkeys (Macaca mulatta). Infect. Immun. 68: 2560-2565 [Abstract] [Full Text]  
  • Weltzin, R., Guy, B., Thomas, W. D. Jr., Giannasca, P. J., Monath, T. P. (2000). Parenteral Adjuvant Activities of Escherichia coli Heat-Labile Toxin and Its B Subunit for Immunization of Mice against Gastric Helicobacter pylori Infection. Infect. Immun. 68: 2775-2782 [Abstract] [Full Text]  
  • Dieterich, C., Bouzourene, H., Blum, A. L., Corthesy-Theulaz, I. E. (1999). Urease-Based Mucosal Immunization against Helicobacter heilmannii Infection Induces Corpus Atrophy in Mice. Infect. Immun. 67: 6206-6209 [Abstract] [Full Text]  
  • ZEVERING, Y, JACOB, L, MEYER, T F (1999). Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development. Gut 45: 465-474 [Full Text]  
  • Covacci, A., Telford, J. L., Giudice, G. D., Parsonnet, J., Rappuoli, R. (1999). Helicobacter pylori Virulence and Genetic Geography. Science 284: 1328-1333 [Abstract] [Full Text]  
  • Brennan, F. R., Bellaby, T., Helliwell, S. M., Jones, T. D., Kamstrup, S., Dalsgaard, K., Flock, J.-I., Hamilton, W. D. O. (1999). Chimeric Plant Virus Particles Administered Nasally or Orally Induce Systemic and Mucosal Immune Responses in Mice. J. Virol. 73: 930-938 [Abstract] [Full Text]  
  • Ermak, T. H., Giannasca, P. J., Nichols, R., Myers, G. A., Nedrud, J., Weltzin, R., Lee, C. K., Kleanthous, H., Monath, T. P. (1998). Immunization of Mice with Urease Vaccine Affords Protection against Helicobacter pylori Infection in the Absence of Antibodies and Is Mediated by MHC Class II-restricted Responses. JEM 188: 2277-2288 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»